1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Karen Rogers
Karen Rogers
Articles (28) 

Elizabeth Arden Releases Q3 2014 Earnings on May 12, 2014

Elizabeth Arden Inc. (NASDAQ:RDEN) will release its third quarter 2014 earnings after the bell at 4:30 p.m., EST, on Monday, May 12, 2014. A simultaneous webcast of the earnings report is available here starting at 4:30 p.m., EST. Elizabeth Arden cosmetics and skin care is sold in over 120 countries. Along with its Red Door line, the company sells celebrity and designer fragrances including Elizabeth Taylor, Halston and Giorgio Beverly Hills.

Analysts Expect:

  • EPS ranging from $-0.09 to $0.03 with a target of $-0.01.
  • Revenue ranging from $247 million to $264 million with a target of $254 million.

Revenue/EPS Recap

Over the past 12 months, Elizabeth Arden has returned a mixed bag of earnings to investors and analysts. The company’s North American sales continue to slide and European sales are still dropping. In the last quarter alone, North American sales fell 13%. The company’s high-end products have fallen out of favor with customers who are looking for similar products at a lower price. Elizabeth Arden adamantly refuses to lower its product prices or revamp specific brands to bolster sagging sales.


Q2 2014

Q1 2014

Q4 2013

Q3 2013
















The economy has not been kind to retailers in general and Elizabeth Arden in particular. The company gutted its revenue estimates for the year and analysts adjusted their expectations accordingly. Since then, the company has missed EPS estimates twice in the past four quarters and only exceeded analyst estimates in first quarter 2014.


Q2 2014

Q1 2014

Q4 2013

Q3 2013

















Elizabeth Arden’s primary competitors are Estee Lauder Companies Inc. (NYSE:EL), Revlon Inc. (NYSE:REV) and Inter Parfum Inc. (NASDAQ:IPAR). Revlon’s first quarter 2014 revenue came in at $470 million while Estee Lauder posted third quarter 2014 revenue of $2.55 billion. Analysts are waiting to see if Elizabeth Arden can post the expected $254 million or if the company will miss the estimate again.











Total Revenue










Projected EPS Growth for 2015





Trade Considerations

Analysts are very bearish on Elizabeth Arden. All seven of the major firms covering Elizabeth Arden rate the company as underperform or neutral. The stock gapped downward on Jan. 16, 2014, from $34.88 to $27.70 on Jan., 17, 2014. When the company announced it had recently hired Goldman Sachs (NYSE:GS) to assist with its potential sale to South Korea's LG Household & Healthcare, the stock gapped up to $33.30. Another potential buyer might be Cody who tried to buy Avon (NYSE:AVP) in 2012 without success. The company may strongly consider selling to LG Household & Healthcare, Cody or a similar suitor should it miss another earnings estimate.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by Karen Rogers

User Generated Screeners

jan.ellsbergerHernhag rev5
jan.ellsbergerHernhag rev4
jan.ellsbergerHernhag rev3
jan.ellsbergerHernhag rev2
BoubaPFS Value Sector
eae010Forward Growth Edited
bpatton23L/Cap value
AJPringAP screen102017 NO LOW
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat